European virtual care is moving past standalone video consultations and into core healthcare infrastructure. Leading platforms now organise triage, routing, scheduling and clinical capacity across payers, employers and provider networks. As adoption spreads and budgets come under scrutiny, differentiation is shifting from features to distribution, regulatory readiness and verifiable operational impact, a combination that is accelerating consolidation.

Three forces are shaping the next phase of M&A.

First, distribution is becoming the primary source of value. Contracted access to insured individuals, employers, or providers increasingly establishes usage, retention and unit economics. These channels are difficult to replicate and are now key in driving valuations, particularly where companies integrate their products directly into existing software rather than being offered as an additional option.

Second, regulatory complexity is a barrier for growth. Governance, data protection and local licensing requirements vary across European markets. Platforms with proven compliance infrastructure can expand across borders with lower execution risk, while smaller single market solutions without establish capability, face rising costs when expanding their geographic footprint leading to slower sales cycles and greater scrutiny.

Third, buyers are focusing on outcomes, not just activity. Investors and strategic buyers are keen to understand the measurable impact of a seller’s product, how it frees up capacity, whether it helps reduce wait times and improves contribution margins for its clients. This pushes the market towards integrated models that combine digital triage, scheduling, and clinical management, rather than isolated tools.

We expect M&A to concentrate on companies that improve new client conversion and retention across the patient journey, with common targets including primary care management, workforce capacity models, and Electronic Health Record (EHR) and insurance claim systems. Deal structures are also likely to be based upon outcomes, with earn-outs and milestones linked to contract wins, retention and performance metrics.

For management teams, a premium valuation will increasingly depend on the quality of earnings and customer concentration, how well they address governance in the market, and evidence that new client adoption translates to operational and financial success.

As consolidation accelerates, successful companies will be those that have a clear operational and product roadmap with access to capital to fund target acquisitions both locally and in other markets.

#Telehealth #MergersAndAcquisitions #CorporateFinance